11/23/2020  6:11:51 PM Chg. - Volume Bid7:59:52 AM Ask7:59:52 AM Market Capitalization Dividend Y. P/E Ratio
124.450EUR - 144
Turnover: 18,037.950
125.900Bid Size: 300 126.800Ask Size: 300 24.12 bill.EUR - -

Business description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Coloplast's business includes ostomy care, urology and continence care, and wound and skin care.
 

Management board & Supervisory board

CEO
Kristian Villumsen
Management board
Anders Lonning-Skovgaard, Allan Rasmussen, Camilla G. Møhl, Nicolai Buhl Andersen, Paul Marcun
Supervisory board
Lars Rasmussen, Birgitte Nielsen, Carsten Hellmann, Jette Nygaard-Andersen, Jørgen Tang-Jensen, Niels Peter Louis-Hansen, Nikolaj Kyhe Gundersen, Roland Vendelbo Pedersen, Thomas Barfod
 

Company data

Name: Coloplast Group
Address: Holtedam 1-3,DK-3050 Humlebaek
Phone: +45-4911-1111
Fax: -
E-mail: coloplast@colopolast.com
Internet: www.coloplast.com/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 64.20%
IPO date: -

Investor relations

Name: Ellen Bjurgert
IR phone: +45-4911-3376
IR Fax: +45-4911-1555
IR e-mail: dkebj@coloplast.com

Company calendar

CW 49 | 12/3/2020 General Shareholder Meeting
CW 50 | 12/8/2020 Dividend Payment
CW 6 | 2/2/2021 Interim Report 1st Quarter/3 Months
CW 19 | 5/6/2021 Interim Report 2nd Quarter/6 Months
CW 34 | 8/18/2021 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
64.20%
Niels Peter Louis-Hansen
 
20.70%
Aage og Johanne Louis-Hanses Fond
 
11.40%
Benedicte Find
 
3.70%